TS Financial Group (TSFG)’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
100
﹤0.01% 851
2026
Q1
$0 Hold
100
﹤0.01% 819
2025
Q4
$0 Hold
100
﹤0.01% 816
2025
Q3
$0 Hold
100
﹤0.01% 828
2025
Q2
$0 Hold
100
﹤0.01% 812
2025
Q1
$0 Hold
100
﹤0.01% 802
2024
Q4
$0 Hold
100
﹤0.01% 745
2024
Q3
$0 Hold
100
﹤0.01% 778
2024
Q2
$0 Hold
100
﹤0.01% 760
2024
Q1
$1K Hold
100
﹤0.01% 704
2023
Q4
$0 Hold
100
﹤0.01% 894
2023
Q3
$1K Hold
100
﹤0.01% 892
2023
Q2
$1K Hold
100
﹤0.01% 886
2023
Q1
$0 Hold
100
﹤0.01% 958
2022
Q4
$0 Hold
100
﹤0.01% 973
2022
Q3
$0 Hold
100
﹤0.01% 955
2022
Q2
$0 Hold
100
﹤0.01% 981
2022
Q1
$0 Hold
100
﹤0.01% 920
2021
Q4
$1K Hold
100
﹤0.01% 806
2021
Q3
$1K Buy
+100
New +$987 ﹤0.01% 789

Other funds holding BDTX

TS Financial Group (TSFG)'s BDTX Position: Q2 2026 in Review

TS Financial Group (TSFG) held its Black Diamond Therapeutics (BDTX) position steady in Q2 2026 at 100 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #851.

TS Financial Group (TSFG) first reported a position in BDTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $1K in Q1 2024. 10 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • TS Financial Group (TSFG) held 100 shares of Black Diamond Therapeutics worth $0 as of Q2 2026.
  • TS Financial Group (TSFG) left its Black Diamond Therapeutics share count unchanged in Q2 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #851 holding.
  • TS Financial Group (TSFG) first reported a position in Black Diamond Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • TS Financial Group (TSFG)'s Black Diamond Therapeutics position peaked at $1K in Q1 2024.
  • 10 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.